Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli
Open Access
- 10 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 62 (3) , 495-503
- https://doi.org/10.1093/jac/dkn222
Abstract
The biological fitness cost of antibiotic resistance is a key parameter in determining the rate of appearance and spread of antibiotic-resistant bacteria. We identified mutations conferring nitrofurantoin resistance and examined their effect on the fitness of clinical Escherichia coli isolates. By plating bacterial cells on agar plates containing nitrofurantoin, spontaneous nitrofurantoin-resistant E. coli mutants were isolated. The fitness of susceptible and resistant strains was measured as growth rate in the presence and absence of nitrofurantoin in rich culture medium. Time–kill kinetics of the resistant mutants was compared with the susceptible strains. Resistance mutations were identified by DNA sequencing. Spontaneous resistant mutants of initially susceptible clinical E. coli appeared with a rate of 10−7/cell/generation, and these mutants showed a reduction in the growth rate compared with the susceptible parent strain. Similarly, comparison of a set of susceptible and resistant clinical isolates of E. coli showed that the average growth rate of the resistant mutants was ∼6% lower than the susceptible strains. Furthermore, the bacterial growth rate in the presence of nitrofurantoin at therapeutic levels was greatly reduced even for nitrofurantoin-resistant mutants. The resistance-conferring mutations were identified in the nsfA and nfsB genes that encode oxygen-insensitive nitroreductases. Nitrofurantoin resistance confers a reduction in fitness in E. coli in the absence of antibiotic. In the presence of therapeutic levels of nitrofurantoin, even resistant mutants are so disturbed in growth that they are probably unable to become enriched and establish an infection.Keywords
This publication has 27 references indexed in Scilit:
- The biological cost of mutational antibiotic resistance: any practical conclusions?Current Opinion in Microbiology, 2006
- Survey on antibiotic usage in the treatment of urinary tract infectionsJournal of Antimicrobial Chemotherapy, 2000
- The ECOSENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim reportJournal of Antimicrobial Chemotherapy, 2000
- The biological cost of antibiotic resistancePublished by Elsevier ,1999
- Mutations to Nitrofurantoin and Nitrofurazone Resistance in Escherichia coli K12Microbiology, 1983
- Type I nitroreductases of Escherichia coliCanadian Journal of Microbiology, 1981
- The Pharmacokinetics of Nitrofurantoin and its Related BioavailabilityPublished by S. Karger AG ,1977
- Nitrofurazone-reducing enzymes in E. coli and their role in drug activation in vivoCanadian Journal of Microbiology, 1975
- Effect of activated nitrofurans on DNABiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1975
- The reduction of Furacin by cell-free extracts of Furacin-resistant and parent-susceptible strains of Escherichia coliArchives of Biochemistry and Biophysics, 1957